This HTML5 document contains 59 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n9http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q56994850
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в червні 2006 wetenschappelijk artikel article im Juni 2006 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q56994850-4EF505B2-32B1-4B02-A8B9-BA632892B0CF
wdt:P577
2006-06-01T00:00:00Z
p:P2093
wds:Q56994850-98A1A4DE-2DCC-4264-9748-370C23882413 wds:Q56994850-4CF910D9-E515-4C62-82EA-B4B0C83429E2
wdt:P2093
Robert L Sutherland Howard A Morris
rdfs:label
Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA
skos:prefLabel
Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA
schema:name
Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA Variants in the Prostate-Specific Antigen (PSA) Gene and Prostate Cancer Risk, Survival, and Circulating PSA
p:P50
wds:Q56994850-39224A9C-18F6-49F1-9877-59D99AB20291 wds:Q56994850-BAC582FE-0900-4012-AD3A-6628F9C08964 wds:Q56994850-07868FB3-DE46-485D-A204-2C551AB19C65 wds:Q56994850-C811FCD2-BD71-4F25-832A-0327EEEB63EE wds:Q56994850-22706E8A-9A1C-4885-B436-F86DC27B2AA6 wds:Q56994850-819D3DBC-6B27-4BD4-846B-FD1AA90C4DED wds:Q56994850-22879908-85A4-41AE-AF05-AD293058D6AE wds:Q56994850-ECF41DA4-08DD-4496-9E37-0E071B9CFE10 wds:Q56994850-CE357114-3D2A-4CCB-B1AE-B07671667676 wds:Q56994850-DC3B47DF-0B17-4B5B-AAEE-0173655AF4BF wds:Q56994850-DCB97FD8-1832-46DF-8DDE-B368C19828B4
wdt:P50
wd:Q114453449 wd:Q56726496 wd:Q57125520 wd:Q55446228 wd:Q40580176 wd:Q2074086 wd:Q63505467 wd:Q89244000 wd:Q30524411 wd:Q114453440 wd:Q28360445
p:P1476
wds:Q56994850-3612F86A-6BBB-4A31-A804-B1FFA8F3112C
wdt:P1476
Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA
p:P304
wds:Q56994850-99FEA8E3-235B-4518-B706-560177815B7E
wdt:P304
1142-1147
p:P31
wds:Q56994850-E5D2958D-555C-4EAB-A31D-EEABC2131343
wdt:P31
wd:Q13442814
p:P921
wds:Q56994850-E4E868D0-0224-4E06-B6AC-AA10FE2A28DF
wdt:P921
wd:Q181257
p:P698
wds:Q56994850-1B529D88-1BCA-428B-AB99-AC05F2A46025
wdtn:P698
n12:16775173
wdt:P698
16775173
p:P1433
wds:Q56994850-8CBF5A73-EA47-47D8-8528-7764E02BD7A8
wdt:P1433
wd:Q326334
p:P433
wds:Q56994850-CABAC0F9-48C4-4E27-81C0-461DF090B996
p:P478
wds:Q56994850-F24ED3B2-B35B-4814-A99A-236D0992F97B
wdt:P433
6
wdt:P478
15
p:P356
wds:Q56994850-BCF55407-A51B-4A1E-B9B3-3DB15A0F97F8
wdtn:P356
n9:1055-9965.EPI-05-0984
wdt:P356
10.1158/1055-9965.EPI-05-0984